|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010186,
umls-concept:C0024752,
umls-concept:C0030193,
umls-concept:C0031117,
umls-concept:C0220812,
umls-concept:C0220825,
umls-concept:C0245561,
umls-concept:C0332281,
umls-concept:C0332293,
umls-concept:C0657912,
umls-concept:C1704738
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-12-8
|
|
pubmed:abstractText |
To evaluate changes in healthcare resource use and costs after initiating pregabalin or duloxetine in employees with pain associated with diabetic peripheral neuropathy (pDPN).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1941-837X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
738-47
|
|
pubmed:meshHeading |
pubmed-meshheading:21091395-Adolescent,
pubmed-meshheading:21091395-Adult,
pubmed-meshheading:21091395-Age Factors,
pubmed-meshheading:21091395-Analgesics,
pubmed-meshheading:21091395-Comorbidity,
pubmed-meshheading:21091395-Diabetic Neuropathies,
pubmed-meshheading:21091395-Female,
pubmed-meshheading:21091395-Health Services,
pubmed-meshheading:21091395-Humans,
pubmed-meshheading:21091395-Insurance Claim Review,
pubmed-meshheading:21091395-Male,
pubmed-meshheading:21091395-Middle Aged,
pubmed-meshheading:21091395-Pain,
pubmed-meshheading:21091395-Sex Factors,
pubmed-meshheading:21091395-Socioeconomic Factors,
pubmed-meshheading:21091395-Thiophenes,
pubmed-meshheading:21091395-Young Adult,
pubmed-meshheading:21091395-gamma-Aminobutyric Acid
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
|
|
pubmed:affiliation |
Thomson Reuters, Healthcare & Science, Washington, DC 19004, USA. jay.margolis@thomsonreuters.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
